Skip to main content

Table 5 Multivariate analysis of overall survival between tamoxifen (TAM) and toremifene (TOR) treated patients

From: A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

 

HR(95%CI)

P value

Age

1.012(0.859-1.192)

0.887

T

0.873(0.156-4.873)

0.877

Grade

1.025(0.376-2.793)

0.962

N

1.656(0.586-4.678)

0.341

Her-2

1.096(0.891-1.347)

0.387

Local control

0.630(0.150-2.643)

0.528

Chemotherapy

0.993(0.441-2.234)

0.987

TAM-TOR

0.000(0.000-6E + 174)

0.955

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us